Novacyt S.A. is an international molecular diagnostics company that develops, manufactures, and commercializes a range of molecular assays and instrumentation. Its operations are divided into three segments: Clinical, which offers in vitro diagnostic products in reproductive health, precision medicine, and infectious diseases; Instrumentation, which includes DNA sample preparation platforms and PCR machines; and Research Use Only services for the life sciences sector. Novacyt serves customers in human health, animal health, and environmental markets, with a commercial presence in over 65 countries, including significant operations in Europe, North America, and Asia-Pacific.